ID18095A - Turunan tetrahidrokinolin - Google Patents

Turunan tetrahidrokinolin

Info

Publication number
ID18095A
ID18095A IDP972834A ID972834A ID18095A ID 18095 A ID18095 A ID 18095A ID P972834 A IDP972834 A ID P972834A ID 972834 A ID972834 A ID 972834A ID 18095 A ID18095 A ID 18095A
Authority
ID
Indonesia
Prior art keywords
tetrahidrokinolin
tetrahidrokinolin down
Prior art date
Application number
IDP972834A
Other languages
English (en)
Inventor
Romano Di-Fabio
Alessandra Pasquarello
Fabio Maria Sabbatini
Original Assignee
Glaxo Wellcome Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome Spa filed Critical Glaxo Wellcome Spa
Publication of ID18095A publication Critical patent/ID18095A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Quinoline Compounds (AREA)
IDP972834A 1996-08-17 1997-08-14 Turunan tetrahidrokinolin ID18095A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9617305.9A GB9617305D0 (en) 1996-08-17 1996-08-17 Heterocyclic compounds

Publications (1)

Publication Number Publication Date
ID18095A true ID18095A (id) 1998-02-26

Family

ID=10798623

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP972834A ID18095A (id) 1996-08-17 1997-08-14 Turunan tetrahidrokinolin

Country Status (34)

Country Link
US (1) US6479488B1 (id)
EP (1) EP0922034B1 (id)
JP (1) JP4108129B2 (id)
KR (1) KR100552864B1 (id)
CN (1) CN1131214C (id)
AP (1) AP877A (id)
AR (1) AR008296A1 (id)
AT (1) ATE221052T1 (id)
AU (1) AU724473B2 (id)
BR (1) BR9711311B1 (id)
CA (1) CA2264118C (id)
CO (1) CO4900066A1 (id)
CZ (1) CZ296250B6 (id)
DE (1) DE69714265T2 (id)
DK (1) DK0922034T3 (id)
EA (1) EA001704B1 (id)
ES (1) ES2181030T3 (id)
GB (1) GB9617305D0 (id)
HU (1) HU225797B1 (id)
ID (1) ID18095A (id)
IL (1) IL128141A0 (id)
IS (1) IS4953A (id)
MY (1) MY116952A (id)
NO (1) NO312241B1 (id)
NZ (1) NZ333812A (id)
PE (1) PE107098A1 (id)
PL (1) PL194532B1 (id)
PT (1) PT922034E (id)
SI (1) SI0922034T1 (id)
TR (1) TR199900336T2 (id)
TW (1) TW449582B (id)
WO (1) WO1998007704A1 (id)
YU (1) YU6799A (id)
ZA (1) ZA977326B (id)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9706294D0 (en) * 1997-03-26 1997-05-14 Glaxo Wellcome Spa Heterocyclic compound
MY125037A (en) * 1998-06-10 2006-07-31 Glaxo Wellcome Spa 1,2,3,4 tetrahydroquinoline derivatives
US6455734B1 (en) 2000-08-09 2002-09-24 Magnesium Diagnostics, Inc. Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
GB9929037D0 (en) * 1999-12-08 2000-02-02 Glaxo Wellcome Spa Heterocyclic derivatives
DE10132725A1 (de) 2001-07-05 2006-08-03 Grünenthal GmbH Substituierte γ-Lactonverbindungen
WO2003057672A2 (en) * 2001-12-28 2003-07-17 Acadia Pharmaceuticals, Inc. Tetrahydroquinoline analogues as muscarinic agonists
JP2006515628A (ja) * 2003-01-23 2006-06-01 アカディア ファーマシューティカルズ，インコーポレーテッド ヒト神経精神疾患を処置するためのｎ−デスメチルクロザピンの使用
US20050085463A1 (en) * 2003-01-23 2005-04-21 Weiner David M. Use of N-desmethylclozapine to treat human neuropsychiatric disease
US20050250767A1 (en) * 2003-01-23 2005-11-10 Weiner David M Use of N-desmethylclozapine to treat human neuropsychiatric disease
US20060233843A1 (en) * 2003-02-19 2006-10-19 Conn P J Treatment of psychosis with a muscarinic m1 receptor ectopic activator
NZ547911A (en) * 2003-12-22 2010-06-25 Acadia Pharm Inc Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders
US20050282800A1 (en) * 2004-04-01 2005-12-22 Bo-Ragnar Tolf Method of synthesis and isolation of solid N-desmethylclozapine and crystalline forms thereof
RU2451014C2 (ru) * 2005-07-22 2012-05-20 Мотида Фармасьютикал Ко., Лтд. Новое производное гетероциклиден ацетамида
EP1908753B1 (en) * 2005-07-22 2014-12-17 Mochida Pharmaceutical Co., Ltd. Novel heterocyclidene acetamide derivative
US8480797B2 (en) 2005-09-12 2013-07-09 Abela Pharmaceuticals, Inc. Activated carbon systems for facilitating use of dimethyl sulfoxide (DMSO) by removal of same, related compounds, or associated odors
EP2324838A1 (en) * 2005-09-12 2011-05-25 Abela Pharmaceuticals, Inc. Compositions Comprising Dimethyl Sulfoxide (DMSO)
WO2007033180A1 (en) 2005-09-12 2007-03-22 Abela Pharmaceuticals, Inc. Materials for facilitating administration of dimethyl sulfoxide (dmso) and related compounds
CA2622204C (en) 2005-09-12 2016-10-11 Abela Pharmaceuticals, Inc. Systems for removing dimethyl sulfoxide (dmso) or related compounds, or odors associated with same
US20070105836A1 (en) * 2005-10-31 2007-05-10 Lars Pettersson Prodrugs of muscarinic agonists and methods of treatment of neuropsychiatric disorders
BRPI0921494A2 (pt) 2008-11-03 2018-10-30 Prad Reasearch And Development Ltd método de planejamento de uma operação de amostragem para uma formação subterrãnea, método de contolar uma operação de amostragem de formação subterrânea, método de controlar uma operação de perfuração para uma formação subterrãnea, e método de realizar uma amostragem durante a operação de perfuração.
EP2493314B1 (en) 2009-10-30 2020-04-08 Abela Pharmaceuticals, Inc. Dimethyl sulfoxide (dmso) and methylsulfonylmethane (msm) formulations to treat osteoarthritis
WO2013055386A2 (en) 2011-10-03 2013-04-18 The University Of Utah Research Foundation Application of 5-ht6 receptor antagonists for the alleviation of cognitive deficits of down syndrome

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL93610A0 (en) * 1989-03-08 1990-12-23 Merck Sharp & Dohme Tetrahydroquinoline derivatives,their preparation and pharmaceutical compositions containing them
JP4108123B2 (ja) * 1995-09-29 2008-06-25 グラクソスミスクライン・ソシエタ・ペル・アチオニ Ｎｍｄａアンタゴニストとしてのテトラヒドロキノリン

Also Published As

Publication number Publication date
DE69714265D1 (de) 2002-08-29
HU225797B1 (en) 2007-09-28
IL128141A0 (en) 1999-11-30
KR100552864B1 (ko) 2006-02-20
DK0922034T3 (da) 2002-11-18
GB9617305D0 (en) 1996-09-25
ATE221052T1 (de) 2002-08-15
PL194532B1 (pl) 2007-06-29
CA2264118C (en) 2008-06-17
MY116952A (en) 2004-04-30
NO990723D0 (no) 1999-02-16
IS4953A (is) 1999-01-22
PT922034E (pt) 2002-12-31
AU4551897A (en) 1998-03-06
TW449582B (en) 2001-08-11
NZ333812A (en) 2000-07-28
ZA977326B (en) 1999-02-15
PL331562A1 (en) 1999-07-19
JP4108129B2 (ja) 2008-06-25
CN1131214C (zh) 2003-12-17
EP0922034A1 (en) 1999-06-16
AR008296A1 (es) 1999-12-29
CA2264118A1 (en) 1998-02-26
DE69714265T2 (de) 2003-03-06
PE107098A1 (es) 1999-01-15
ES2181030T3 (es) 2003-02-16
US6479488B1 (en) 2002-11-12
SI0922034T1 (en) 2003-02-28
AU724473B2 (en) 2000-09-21
CN1227544A (zh) 1999-09-01
EP0922034B1 (en) 2002-07-24
AP9901459A0 (en) 1999-03-31
JP2001508031A (ja) 2001-06-19
HUP9903108A3 (en) 2004-04-28
KR20000068172A (ko) 2000-11-25
CZ296250B6 (cs) 2006-02-15
EA199900121A1 (ru) 1999-10-28
BR9711311B1 (pt) 2009-01-13
AP877A (en) 2000-09-27
BR9711311A (pt) 1999-08-17
CZ52999A3 (cs) 1999-07-14
TR199900336T2 (xx) 1999-04-21
NO312241B1 (no) 2002-04-15
YU6799A (sh) 2000-03-21
EA001704B1 (ru) 2001-06-25
CO4900066A1 (es) 2000-03-27
NO990723L (no) 1999-04-14
WO1998007704A1 (en) 1998-02-26

Similar Documents

Publication Publication Date Title
DE69739832D1 (de) Nähfadenankeranordnung
DE69714049D1 (de) Hochleistungsionomermischung
DE69737638D1 (de) Giesstauschrohr
DK0882051T3 (da) Thiophenopyrimidiner
DE69739289D1 (de) Chtoberflächenwellenresonatoren
DE69721271D1 (de) Handstaubsauger
DE69714697D1 (de) Bisbenzotrialzolylphenole
FI100547B (fi) Alipaineklosetti
BR9711066A (pt) Arilacanoilpiridazinas
ID19474A (id) Turunan tiazola
DE69720749D1 (de) Zielanvisierungssystem
DE69708269D1 (de) Chinoxalindione
DE69709668D1 (de) Viskositätsindexverbesserungsdispergiermittel
FI101456B1 (fi) Monisylinteripipetti
ID18095A (id) Turunan tetrahidrokinolin
DE69729418D1 (de) Kartenauswerfgerät
DE69709906D1 (de) Schienenpolymerbettung
DE69710641D1 (de) Zweierkomplementmultiplizierer
DE69726186D1 (de) Förderband
ATE353652T1 (de) Östroprogestatives antikonzeptionsmittel
DE69722729D1 (de) Reibschweissgerät
DE69713891D1 (de) Polymerentgasung
DE69734273T2 (de) Zylinderkopfdichtung
DE69721193D1 (de) Kupplungsausrüstvorrichtung
DE69717839D1 (de) Pfilzenbearbeitung